Advanced Therapies: CRISPR 2.0

Please join us for an installment of Yale Startups in Formation, Advanced Therapies. In this session we will address the key challenges of bringing CRISPR-based therapeutics to the clinic. It is becoming increasingly important for clinicians to understand what needs to happen for CRISPR to become a meaningful therapeutic modality.

HOST: Dr. James Boyle, Exec. Director of Venture Development, OCR

MODERATOR: Roy S. Herbst, MD, PhD, Ensign Professor of Medicine, Professor of Pharmacology, Chief of Medical Oncology, Director, Thoracic Oncology Research Program Associate Director for Translational Research, Yale Comprehensive Cancer Center, Yale School of Medicine

FEATURED SPEAKERS:

• Dr. Dmitry ‘Dima’ Kuzmin MSc, Managing Partner of 4BIO Capital & Assistant Professor Adjunct of Medicine (Medical Oncology), Yale School of Medicine
• Christina Trojel-Hansen, PhD, EIR, ARCH Venture Partners